The medical workers are charged with deliberately contaminating more than 400 children with HIV in 1998. However, new evidence published online in Nature from the Evolutionary Biology Group at Oxford, in collaboration with several European universities, shows that the subtype of HIV involved began infecting patients well before the medical workers arrived in Libya.
Researchers used the genetic sequences of HIV and Hepatitis C viruses that were isolated from the patients to reconstruct the transmission history of the strains involved and work out when the outbreaks began. By analysing mutations that accumulate over time, they were able to work out the timescale of the outbreaks and when they started. A body of scientific evidence already indicates that the outbreak was caused by poor hospital hygiene and not by deliberate transmission. These results provide the first direct molecular evidence.
For ten years the Evolutionary Biology Group has been developing and honing state-of-the-art methods for reconstructing the epidemic and evolutionary history of viruses from genetic data, and have researched both HIV and the Hepatitis C Virus. Authors Dr Tulio de Oliveira,Dr Oliver Pybus and Dr Andrew Rambautare world experts on this type of analysis. Together they worked around the clock to analyse the genomes of the viruses isolated from blood samples collected by a network of European clinical research centres that are involved in treating the infected children.
Dr Oliver Pybus said: ‘We've demonstrated that the HIV and Hepatitis C Virus strains involved in the Al Fateh Hospital outbreaks were present and being transmitted locally for some time before the arrival of the Bulgarian medical staff.’
The trial of the six workers, which has been taking place in Tripoli, ended on 4 November and a verdict is expected on 19 December.
Last month 114 Nobel Laureates wrote an open letter to Colonel Gaddafi urging the appropriate authorities to hear independent science-based evidence, and reaffirming the need for a fair trial. The new research represents a thorough and peer-reviewed scientific investigation of the new genetic and molecular data available from the outbreaks.
Lead author Dr Tulio de Oliveira said: ‘All the lines of scientific evidence point in the same direction: towards a longstanding infection control problem at the hospital, dating back to the mid 1990s or earlier.’
Source: University of Oxford
Related stories:
New nano device detects immune system cell signaling
Scientists have detected previously unnoticed chemical signals that individual cells in the immune system use to communicate with each other over short distances.
ABC-transporters expressed on endothelial cell membranes efflux anti-HIV drugs
Researchers at Tulane University Medical Center in New Orleans (USA) have discovered that drug-efflux pumps, belonging to the ATP-binding cassette (ABC) transporter family, are constitutively expressed on vascular endothelial cells. Transcripts for several different ABC-transporters, e.g. MDR-1 (P-gp) and MRPs, were detected in endothelial cells, obtained from brain, aortic artery, pulmonary artery, dermal microvessels and umbilical veins.
Victims of Britain's tainted blood scandal speak
(AP) -- Robert Mackie trembles with rage when he describes how he and his wife were kept in the dark about his HIV infection - and how doctors published his medical data in journals years before they gave him the devastating news.
Operations research promises continued gains for HIV treatment in resource-limited countries
In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.
Chemical liberated by leaky gut may allow HIV to infect the brain
In up to 20 percent of people infected with HIV, the virus manages to escape from the bloodstream and cross into the brain, resulting in HIV-associated dementia and other cognitive disorders. Now, scientists at the Albert Einstein College of Medicine of Yeshiva University have found strong evidence that a component of the cell walls of intestinal bacteria—a chemical present in high levels in the blood of HIV-infected people—helps HIV to penetrate the usually-impregnable blood brain barrier (BBB). The findings, published in the August issue of the
Journal of Virology, could lead to strategies for preventing HIV from entering the brain and causing serious complications.
Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs
AIDS experts at Johns Hopkins say they have compelling evidence that some people with HIV who for years and even decades show extremely low levels of the virus in their blood never progress to full-blown AIDS and remain symptom free even without treatment, probably do so because of the strength of their immune systems, not any defects in the strain of HIV that infected them in the first place.
Researchers to begin study aimed at helping Latino HIV patients
Researchers at Wake Forest University Baptist Medical Center will soon begin researching how a lack of trust in formal medicine is contributing to disproportionately higher mortality rates in Latino HIV patients than in white HIV patients across the country.
'Silencing' HIV with small bits of RNA
Researchers have shown that they can effectively tackle HIV-1 with small bits of gene-silencing RNA by delivering them directly to infected T cells, the major targets of the virus. While earlier studies had shown such a strategy could fight against many viruses including HIV-1, the new study in mice with human blood cells, so-called humanized mice, is the first to demonstrate an effective approach to systemic delivery in a living animal.
